How Unavoidable Are Analytical Treatment Interruptions in HIV Cure-Related Studies?
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 31264691.
- Also identified by DOI 10.1093/infdis/jiz222 and PMC identifier 6636248.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this discussion, 2 established researchers and clinical trialists debate their opposing views on the utility, benefits, and risks of the use of analytical interruption of antiretroviral therapy as a clinical trial end point and outcome measure in human studies seeking to induce remission of or eradicate human immunodeficiency virus infection.
Medical subject headings
- Anti-HIV Agents
- Coinfection
- HIV Infections
- Vaccines
- Withholding Treatment